Loading...

ENDRA Life Sciences Inc.

NDRANASDAQ
Healthcare
Medical - Diagnostics & Research
$5.82
$-0.53(-8.35%)

ENDRA Life Sciences Inc. (NDRA) Company Profile & Overview

Explore ENDRA Life Sciences Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

ENDRA Life Sciences Inc. (NDRA) Company Profile & Overview

ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

SectorHealthcare
IndustryMedical - Diagnostics & Research
CEOAlexander Y. Tokman

Contact Information

734 335 0468
3600 Green Court, Ann Arbor, MI, 48105-1570

Company Facts

21 Employees
IPO DateJun 30, 2017
CountryUS
Actively Trading

Frequently Asked Questions

;